Skip to search.
 All Ordinaries Up 0.51%

More On ACL.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Alchemia Ltd (ACL.AX)

-ASX
0.04 Up 0.01(15.62%) 31 Jul 16:10
Add to Portfolio
Prev Close:0.03
Open:0.03
Bid:0.04
Ask:0.04
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.03 - 0.04
52wk Range:0.03 - 0.68
Volume:435,473
Avg Vol (3m):2,349,450
Market Cap:12.01M
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alchemia Limited, a biotechnology company, develops human therapeutic products based on its proprietary drug discovery, drug targeting, and synthesis technologies in Australia and the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback